Annual SG&A
$59.83 M
+$10.88 M+22.23%
31 December 2023
Summary:
Bicycle Therapeutics annual selling, general & administrative expenses is currently $59.83 million, with the most recent change of +$10.88 million (+22.23%) on 31 December 2023. During the last 3 years, it has risen by +$30.63 million (+104.90%). BCYC annual SG&A is now at all-time high.BCYC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$17.94 M
+$1.89 M+11.76%
30 September 2024
Summary:
Bicycle Therapeutics quarterly selling, general & administrative expenses is currently $17.94 million, with the most recent change of +$1.89 million (+11.76%) on 30 September 2024. Over the past year, it has increased by +$2.37 million (+15.23%). BCYC quarterly SG&A is now at all-time high.BCYC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.26 B
-$166.28 M-7.95%
30 September 2024
Summary:
Bicycle Therapeutics TTM selling, general & administrative expenses is currently -$2.26 billion, with the most recent change of -$166.28 million (-7.95%) on 30 September 2024. Over the past year, it has dropped by -$2.31 billion (-4167.31%). BCYC TTM SG&A is now -3127.18% below its all-time high of $65.49 million, reached on 30 September 2024.BCYC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCYC Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +22.2% | +15.2% | -4167.3% |
3 y3 years | +104.9% | +117.0% | -6764.8% |
5 y5 years | +636.8% | +274.6% | -10000.0% |
BCYC Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +104.9% | at high | +117.0% | -220.0% | at low |
5 y | 5 years | at high | +636.8% | at high | +428.2% | -585.7% | at low |
alltime | all time | at high | +833.9% | at high | +953.9% | -3127.2% | at low |
Bicycle Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $17.94 M(+11.8%) | $65.49 M(+3.8%) |
June 2024 | - | $16.05 M(-2.4%) | $63.12 M(+1.4%) |
Mar 2024 | - | $16.45 M(+9.3%) | $62.25 M(+4.0%) |
Dec 2023 | $59.83 M(+22.2%) | $15.05 M(-3.3%) | $59.83 M(+7.8%) |
Sept 2023 | - | $15.57 M(+2.6%) | $55.49 M(+10.6%) |
June 2023 | - | $15.18 M(+8.1%) | $50.17 M(+8.7%) |
Mar 2023 | - | $14.04 M(+31.0%) | $46.14 M(-5.7%) |
Dec 2022 | $48.95 M(+50.9%) | $10.71 M(+4.6%) | $48.95 M(+4.2%) |
Sept 2022 | - | $10.25 M(-8.0%) | $46.96 M(+4.4%) |
June 2022 | - | $11.14 M(-33.8%) | $44.98 M(+9.2%) |
Mar 2022 | - | $16.85 M(+93.1%) | $41.18 M(+27.0%) |
Dec 2021 | $32.44 M | $8.72 M(+5.5%) | $32.43 M(-4.2%) |
Sept 2021 | - | $8.27 M(+12.6%) | $33.87 M(+5.8%) |
June 2021 | - | $7.35 M(-9.3%) | $32.01 M(+3.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $8.10 M(-20.3%) | $30.95 M(+11.1%) |
Dec 2020 | $29.20 M(+100.6%) | $10.16 M(+58.6%) | $27.86 M(+32.1%) |
Sept 2020 | - | $6.41 M(+1.8%) | $21.09 M(+8.3%) |
June 2020 | - | $6.29 M(+25.9%) | $19.48 M(+20.6%) |
Mar 2020 | - | $5.00 M(+47.2%) | $16.16 M(+11.0%) |
Dec 2019 | $14.56 M(+79.3%) | $3.40 M(-29.1%) | $14.56 M(+9.7%) |
Sept 2019 | - | $4.79 M(+61.1%) | $13.27 M(+22.8%) |
June 2019 | - | $2.97 M(-12.6%) | $10.81 M(+13.3%) |
Mar 2019 | - | $3.40 M(+61.5%) | $9.54 M(+17.4%) |
Dec 2018 | $8.12 M(+26.8%) | $2.11 M(-9.4%) | $8.12 M(+35.0%) |
Sept 2018 | - | $2.33 M(+36.6%) | $6.01 M(+63.0%) |
June 2018 | - | $1.70 M(-14.4%) | $3.69 M(+85.6%) |
Mar 2018 | - | $1.99 M | $1.99 M |
Dec 2017 | $6.41 M | - | - |
FAQ
- What is Bicycle Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual SG&A year-on-year change?
- What is Bicycle Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly SG&A year-on-year change?
- What is Bicycle Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM SG&A year-on-year change?
What is Bicycle Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of BCYC is $59.83 M
What is the all time high annual SG&A for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual selling, general & administrative expenses is $59.83 M
What is Bicycle Therapeutics annual SG&A year-on-year change?
Over the past year, BCYC annual selling, general & administrative expenses has changed by +$10.88 M (+22.23%)
What is Bicycle Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BCYC is $17.94 M
What is the all time high quarterly SG&A for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly selling, general & administrative expenses is $17.94 M
What is Bicycle Therapeutics quarterly SG&A year-on-year change?
Over the past year, BCYC quarterly selling, general & administrative expenses has changed by +$2.37 M (+15.23%)
What is Bicycle Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of BCYC is -$2.26 B
What is the all time high TTM SG&A for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM selling, general & administrative expenses is $65.49 M
What is Bicycle Therapeutics TTM SG&A year-on-year change?
Over the past year, BCYC TTM selling, general & administrative expenses has changed by -$2.31 B (-4167.31%)